Kreutzman A - Search Results

1

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia.

Cuesta-Mateos C, Fuentes P, Schrader A, Juárez-Sánchez R, Loscertales J, Mateu-Albero T, Vega-Piris L, Espartero-Santos M, Marcos-Jimenez A, Sánchez-López BA, Pérez-García Y, Jungherz D, Oberbeck S, Wahnschaffe L, Kreutzman A, Andersson EI, Mustjoki S, Faber E, Urzainqui A, Fresno M, Stamatakis K, Alfranca A, Terrón F, Herling M, Toribio ML, Muñoz-Calleja C. Cuesta-Mateos C, et al. Among authors: kreutzman a. Biomark Res. 2020 Oct 24;8:54. doi: 10.1186/s40364-020-00234-z. eCollection 2020. Biomark Res. 2020. PMID: 33110606 Free PMC article.

2

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy.

Kreutzman A, Juvonen V, Kairisto V, Ekblom M, Stenke L, Seggewiss R, Porkka K, Mustjoki S. Kreutzman A, et al. Blood. 2010 Aug 5;116(5):772-82. doi: 10.1182/blood-2009-12-256800. Epub 2010 Apr 22. Blood. 2010. PMID: 20413659 Free article.

3

Poor cytokine-induced phosphorylation in chronic myeloid leukemia patients at diagnosis is effectively reversed by tyrosine kinase inhibitor therapy.

Jalkanen SE, Vakkila J, Kreutzman A, Nieminen JK, Porkka K, Mustjoki S. Jalkanen SE, et al. Among authors: kreutzman a. Exp Hematol. 2011 Jan;39(1):102-113.e1. doi: 10.1016/j.exphem.2010.09.005. Epub 2010 Oct 12. Exp Hematol. 2011. PMID: 20869423

4

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.

Kreutzman A, Rohon P, Faber E, Indrak K, Juvonen V, Kairisto V, Voglová J, Sinisalo M, Flochová E, Vakkila J, Arstila P, Porkka K, Mustjoki S. Kreutzman A, et al. PLoS One. 2011;6(8):e23022. doi: 10.1371/journal.pone.0023022. Epub 2011 Aug 9. PLoS One. 2011. PMID: 21857985 Free PMC article.

5

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.

Kreutzman A, Jaatinen T, Greco D, Vakkila E, Richter J, Ekblom M, Hjorth-Hansen H, Stenke L, Melo T, Paquette R, Seggewiss-Bernhardt R, Guerci-Bresler A, Talbot A, Cayuela JM, Mahon FX, Porkka K, Lipton J, Partanen J, Rousselot P, Mustjoki S. Kreutzman A, et al. Exp Hematol. 2012 Nov;40(11):906-913.e1. doi: 10.1016/j.exphem.2012.07.007. Epub 2012 Jul 25. Exp Hematol. 2012. PMID: 22842045 Free article.

6

Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy.

Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, Vakkila J, Mustjoki S. Ilander M, et al. Among authors: kreutzman a. PLoS One. 2014 Jan 31;9(1):e87794. doi: 10.1371/journal.pone.0087794. eCollection 2014. PLoS One. 2014. PMID: 24498197 Free PMC article. Clinical Trial.

7

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia.

Ilander M, Kreutzman A, Mustjoki S. Ilander M, et al. Among authors: kreutzman a. Oncoimmunology. 2014 Apr 29;3:e28781. doi: 10.4161/onci.28781. eCollection 2014. Oncoimmunology. 2014. PMID: 25050224 Free PMC article.

8

Dasatinib promotes Th1-type responses in granzyme B expressing T-cells.

Kreutzman A, Ilander M, Porkka K, Vakkila J, Mustjoki S. Kreutzman A, et al. Oncoimmunology. 2014 May 29;3:e28925. doi: 10.4161/onci.28925. eCollection 2014. Oncoimmunology. 2014. PMID: 25083322 Free PMC article.

9

Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.

Cuesta-Mateos C, Loscertales J, Kreutzman A, Colom-Fernández B, Portero-Sáinz I, Pérez-Villar JJ, Terrón F, Muñoz-Calleja C. Cuesta-Mateos C, et al. Among authors: kreutzman a. Cancer Immunol Immunother. 2015 Jun;64(6):665-76. doi: 10.1007/s00262-015-1670-z. Epub 2015 Feb 28. Cancer Immunol Immunother. 2015. PMID: 25724841 Free PMC article.

10

A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD.

Portero-Sainz I, Gómez-García de Soria V, Cuesta-Mateos C, Fernández-Arandojo C, Vega-Piris L, Royg M, Colom-Fernández B, Marcos-Jiménez A, Somovilla-Crespo B, Ramírez-Mengíbar A, López-Huete V, de Rosendo-Serrano A, Kreutzman A, Muñoz-Calleja C. Portero-Sainz I, et al. Among authors: kreutzman a. Bone Marrow Transplant. 2017 May;52(5):745-752. doi: 10.1038/bmt.2016.342. Epub 2017 Jan 23. Bone Marrow Transplant. 2017. PMID: 28112745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page